Jane Street’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-203,665
| Closed | -$866K | – | 11790 |
|
|
2025
Q4 | $866K | Buy |
203,665
+129,670
| +175% | +$664K | ﹤0.01% | 6429 |
|
|
2025
Q3 | $396K | Sell |
73,995
-64,593
| -47% | -$350K | ﹤0.01% | 8345 |
|
|
2025
Q2 | $747K | Buy |
138,588
+107,156
| +341% | +$425K | ﹤0.01% | 6166 |
|
|
2025
Q1 | $88.7K | Sell |
31,432
-15,149
| -33% | -$52.7K | ﹤0.01% | 8865 |
|
|
2024
Q4 | $146K | Sell |
46,581
-32,666
| -41% | -$94.2K | ﹤0.01% | 8600 |
|
|
2024
Q3 | $235K | Buy |
79,247
+55,867
| +239% | +$184K | ﹤0.01% | 8411 |
|
|
2024
Q2 | $77.5K | Buy |
+23,380
| New | +$76.5K | ﹤0.01% | 8819 |
|
|
2024
Q1 | – | Sell |
-75,438
| Closed | -$321K | – | 9324 |
|
|
2023
Q4 | $321K | Buy |
75,438
+50,427
| +202% | +$274K | ﹤0.01% | 7501 |
|
|
2023
Q3 | $171K | Sell |
25,011
-20,976
| -46% | -$185K | ﹤0.01% | 7723 |
|
|
2023
Q2 | $482K | Buy |
+45,987
| New | +$411K | ﹤0.01% | 6373 |
|
|
2022
Q3 | – | Sell |
-159,247
| Closed | -$1.86M | – | 9806 |
|
|
2022
Q2 | $2.14M | Buy |
159,247
+101,578
| +176% | +$1.68M | ﹤0.01% | 4040 |
|
|
2022
Q1 | $1.12M | Buy |
57,669
+49,345
| +593% | +$985K | ﹤0.01% | 5892 |
|
|
2021
Q4 | $287K | Sell |
8,324
-68,945
| -89% | -$2.77M | ﹤0.01% | 8243 |
|
|
2021
Q3 | $4.23M | Buy |
77,269
+14,768
| +24% | +$890K | ﹤0.01% | 3013 |
|
|
2021
Q2 | $4.59M | Buy |
62,501
+54,406
| +672% | +$5.44M | ﹤0.01% | 2796 |
|
|
2021
Q1 | $741K | Sell |
8,095
-54,749
| -87% | -$5.31M | ﹤0.01% | 6049 |
|
|
2020
Q4 | $5.09M | Buy |
62,844
+26,323
| +72% | +$2.02M | ﹤0.01% | 2110 |
|
|
2020
Q3 | $1.7M | Buy |
+36,521
| New | +$2.04M | ﹤0.01% | 3291 |
|
Jane Street's CVAC Position: Q1 2026 in Review
Jane Street sold out of CureVac (CVAC) in Q1 2026, closing a stake of 203,665 shares — an estimated $866K sold.
Jane Street first reported a position in CVAC in Q3 2020 and held it in 18 quarters. The position peaked at $5.09M in Q4 2020. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Jane Street reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 203,665 CureVac shares in Q1 2026, an estimated $866K.
- Jane Street first reported a position in CureVac in Q3 2020 and held it in 18 quarters.
- Jane Street's CureVac position peaked at $5.09M in Q4 2020.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.